SHINE Opens New Facility
SHINE Technologies announced today it is opening the largest facility in North America dedicated to producing a medical isotope used in targeted cancer therapies. According to a release, the facility,…
SHINE Technologies announced today it is opening the largest facility in North America dedicated to producing a medical isotope used in targeted cancer therapies. According to a release, the facility,…
SHINE Technologies is now offering state-of-the-art radiation effects testing, the company announced today. According to a release, the service, called FLARE (Fusion Linear Accelerator for Radiation Effects), will use high-energy…
SHINE Technologies and Radiopharm Theranostics signed a clinical supply agreement, in which SHINE will supply Radiopharm with isotope non-carrier-added lutetium-177 (Lu-177), the company announced recently. “One way or another, nearly…
SHINE Technologies named Tom D’Orazio as the CEO of Phoenix, the company announced recently. According to a release, D’Orazio has more than two decades of experience in sales leadership roles…
SHINE Technologies has submitted a Drug Master File (DMF) with the U.S. Food and Drug Administration for non-carrier-added lutetium-177 (Lu-177) chloride, the company announced recently. According to a release, the…
SHINE Technologies announced recently that Holli C. Ladhani and Janet S. Wong have joined its board of directors. “We are excited to bring these two highly talented individuals to our…
SHINE Technologies announced recently that it will supply ImaginAb Inc., a global biotechnology company focused on developing immuno-oncology imaging agents and therapeutic radiopharmaceuticals, with lutetium-177 (Lu-177) to support the company’s…
SHINE Technologies announced today that it has signed a contract with the Department of Energy as part of its Uranium Lease and Take-back Program. According to a release, SHINE will…
SHINE Medical Technologies has changed its name to SHINE Technologies, the company announced today. According to a release, the new name highlights the company’s core technological competencies, skilled team and…
SHINE Medical Technologies has completed a $150 million Series C-5 financing round led by Koch Disruptive Technologies (KDT), with participation from Fidelity Management & Research Company, Baillie Gifford and other…